Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 16.72
-0.17 (-0.98%)
Jun 9, 2026, 3:59 PM EST
Cipher Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cipher Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $20.64. The average 1-year stock price forecast is 23.48% higher than the current stock price, while the lowest is $17.00 (+1.71%) and the highest is $22.25 (+33.11%).
Price Target: $20.64 (+23.48%)
Analyst Consensus: Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Cipher Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $21.00 → $22.00 | Buy | Reiterates | $21.00 → $22.00 | +31.62% | May 11, 2026 |
Financial Forecast
Revenue This Year
53.68M
from 50.45M
Increased by 6.41%
Revenue Next Year
62.05M
from 53.68M
Increased by 15.58%
EPS This Year
n/a
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 54.7M | ||
| Avg | 53.7M | ||
| Low | 51.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.4% | ||
| Avg | 6.4% | ||
| Low | 2.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |